Hey All
I am setting a target price value of the HBRM for the CHRI to buy it.
Today the MKCAP of HBRM was 300k to start the day.
Now with this in Mind and with the projected revs for 2012 of CHRI at 70 million according to the news release we need to figure the value of the HBRM management team for the US entry.
HBRM I feel is the missing key to the US opening of CHRI they needed for years now that we have been following the CHRI.
CHRI is projecting the revs to double this next year adding the US market and HBRM is set to help that grow.
With this increase in the US I see 30 million as the revs ahead or more for the US.
Now I am confident the HBRM also sees this same number and with 300 million shares on the market knows there value on the buyout to be around one tenth the 30 million market in the US.
With this thought in mind and dividing that own to a HBRM possible value of the deal at 3 million MKCAP is see the very real possibly of 1.5 million to 3 million MKCAP this week ahead of news for HBRM.
Simply stated that leaves a pps possibility of .007 to .015 on the price based on the momentum.
For those looking at long range when the buyout is done and the next year I see the next two quarters raising the awareness of CHRI solidly over the dime.
Short term both are a buy with the HBRM possible for 200 to 300% more this week and CHRI the next three months the same in price.
Good luck and make sure you take a profit on the move up.
TruckerDave
Hey All I am setting a target price value of the HBRM for
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Lumexa Imaging's Investor Conference Push: Any Real Substance?
Lumexa Imaging just dropped a line on Feb 17, 2026, about their upcoming investor conference gigs. Sure, they're strutting into multiple events—Raymond James in Orlando, Leerink Partners in Miami, and Barclays back-to-back days after that. But here’s the kicker: are these talks really worth the buzz? In a space where outpatient imaging claims to be kingpin, you’ve...
Continue Reading
Current Landscape of US Stock Futures Amid Rate Cuts
Insights on the Current Stability of U.S. Stock Futures During Asian trading hours, U.S. stock index futures have held steady. Investors are hoping for interest rate cuts as the Federal Reserve's next meeting approaches. This meeting is expected to reveal a significant easing cycle that many in the market are eagerly anticipating. Even with strong reports on consumer and...
Continue Reading
Wispr Flow Revolutionizes Voice Dictation Across Platforms
Wispr Flow Expands Its Reach in Voice Dictation Technology In a world where speed and efficiency are paramount, Wispr, known as The Voice Interface Company, is revolutionizing the way we interact with technology. With the recent launch of Wispr Flow for Windows, this innovative voice productivity tool is now accessible to users across both Mac and Windows platforms,...
Continue Reading
MintMiner: Your Ultimate Gateway to Cloud Mining Success
Unlocking the Future of Cloud Mining with MintMiner In today's uncertain financial landscape, MintMiner presents an innovative solution for anyone looking to tap into the world of digital assets. As global financial systems face challenges, MintMiner offers a unique platform that makes cloud mining accessible, straightforward, and profitable. Understanding Cloud Mining...
Continue Reading
GT Biopharma's Strategic Move: Withdrawal of S-1 Registration
GT Biopharma's Strategic Withdrawal of Form S-1 Registration GT Biopharma, Inc. (NASDAQ: GTBP) recently made headlines with its request for withdrawal of a Form S-1 registration statement. This decision marks a crucial moment for the company, based in San Francisco, known for its innovative approach in the immuno-oncology sector. GT Biopharma focuses on the development of...
Continue Reading